These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1769 related items for PubMed ID: 15163339

  • 1. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 2. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
    Iglesias P, Grande C, Méndez J, Fernandez-Reyes MJ, Bajo MA, Selgas R, Díez JJ.
    Adv Perit Dial; 1996 Jun; 12():71-6. PubMed ID: 8865877
    [Abstract] [Full Text] [Related]

  • 3. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):68-73. PubMed ID: 16402931
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 6. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [Abstract] [Full Text] [Related]

  • 7. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.
    Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M.
    Growth Horm IGF Res; 2005 Dec; 15(6):369-76. PubMed ID: 16198134
    [Abstract] [Full Text] [Related]

  • 9. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 10. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis.
    Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, Peteiro J, García-Naveiro R, García-Buela J.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2095-100. PubMed ID: 15187192
    [Abstract] [Full Text] [Related]

  • 11. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 12. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ, Luo SM, Hu WJ.
    Zhonghua Wai Ke Za Zhi; 2005 Jun 01; 43(11):697-701. PubMed ID: 16008955
    [Abstract] [Full Text] [Related]

  • 13. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct 01; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]

  • 14. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
    Reeves I, Abribat T, Laramee P, Jasmin G, Brazeau P.
    Growth Horm IGF Res; 2000 Apr 01; 10(2):78-84. PubMed ID: 10931745
    [Abstract] [Full Text] [Related]

  • 15. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B, Kural N, Colak O, Ak I, Akcar N.
    Clin Physiol Funct Imaging; 2008 Mar 01; 28(2):107-12. PubMed ID: 18093232
    [Abstract] [Full Text] [Related]

  • 16. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.
    Eur J Clin Nutr; 2006 Jun 01; 60(6):718-26. PubMed ID: 16391585
    [Abstract] [Full Text] [Related]

  • 17. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Minerva Endocrinol; 1999 Jun 01; 24(2):51-5. PubMed ID: 10941423
    [Abstract] [Full Text] [Related]

  • 18. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
    Wan Nazaimoon WM, Osman A, Wu LL, Khalid BA.
    Clin Endocrinol (Oxf); 1996 Jul 01; 45(1):79-83. PubMed ID: 8796142
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R.
    Hepatology; 1995 Mar 01; 21(3):680-8. PubMed ID: 7533122
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ, Grande C, Méndez J, González-Gancedo P, Iglesias P.
    Clin Endocrinol (Oxf); 2006 Jul 01; 65(1):27-34. PubMed ID: 16817815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 89.